Now, Oxford and Oracle have created a Global Pathogen Analysis System combining Oxford's Scalable Pathogen Pipeline Platform (SP3) with cloud computing infrastructure. First used for tuberculosis, SP3 has been repurposed to unify, standardise, analyse, and compare sequence data of Sars-CoV-2, yielding annotated genomic sequences and identifying new variants and those of concern. SP3's processing capability has been enhanced with extensive new development work from Oracle. The SP3 system will now deliver comprehensive and standardised results of Covid-19 analyses within minutes of submission on an international scale. The results will be shared with countries around the globe in a secure environment.